Skip to content

De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06934564
Enrollment
16
Registered
2025-04-18
Start date
2025-04-01
Completion date
2026-12-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Lumpectomy, Inguinal Hernia Repair, Laparoscopic Cholecystectomy

Keywords

Preoperative testing

Brief summary

This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.

Interventions

BEHAVIORALActive de-Implementation

During active de-implementation (3 months), the local team will distribute the strategy components (i.e., clinician education, decision support, evaluation, consensus building around perioperative testing pathways, facility-specific feedback, and a pay-for-performance incentive) at the local site.

Sponsors

University of Michigan
Lead SponsorOTHER
Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Blue Cross Blue Shield of Michigan Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Using a stepped wedge design, sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement a multi-level, multi-component de-implementation strategy and collect information on the use of unnecessary preoperative testing.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Site Inclusion Criteria: * Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)

Exclusion criteria

* none Surgical participants must be over 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
Number of tests within 30 days of surgery not associated with an emergency department visitWithin 30 days of surgeryOnly tests relating to three index procedures; breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair Data collected using MVC/MSQC database

Secondary

MeasureTime frameDescription
Number of unnecessary preoperative testing before low-risk surgery at MVC/MSQC sites not participating in the trialUp to year 2, quarter 4Example related operations: laparoscopic hysterectomy, knee arthroscopy
30-day episode-based spendingUp to Year 2, Quarter 2Using the MVC claims data for total spending amounts
Number of unnecessary preoperative testing before low-risk surgery at trial sitesUp to year 2, quarter 4Example related operations: laparoscopic hysterectomy, knee arthroscopy
Number of intraoperative complicationsUp to year 2, quarter 4Examples: myocardial infarction, stroke
Number of same-day case cancellationsUp to year 2, quarter 4

Countries

United States

Contacts

CONTACTDana Greene Jr., MPH
greenejr@med.umich.edu(313)-670-0408
CONTACTValerie Gavrila
gavrilva@umich.edu734-232-9961
PRINCIPAL_INVESTIGATORLesly Dossett, MD, MPH

University of Michigan

PRINCIPAL_INVESTIGATORHari Nathan, PhD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026